** Shares of MedAdvisor MDR.AX rise 30% to A$0.13, hitting their highest levels since March 5
** The pharmaceutical co says it received a non-binding letter of intent (LOI) from a listed multinational software business with operations in Australia
** The LOI outlines a proposal to acquire the company's ANZ business division for cash - co
** It did not reveal any other details of the LOI
** Stock is biggest percentage gainer in the ASX All Ordinaries Index .AORD
** Over 1 million shares change hands, vs the 30-day average of almost 700,000
** Stock rose as much as 65% earlier in the day, marking its biggest intraday gain since March 10, 2020
** MDR stock down 55.6%, YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.